Fig. 2.
A comparison of novel biomarkers between acute kidney injury (AKI) and non-AKI patients: (A) urinary L-FABP, (B) urinary NGAL, and (C) serum L-FABP were significantly higher in AKI than in non-AKI patients at 4 and 12 hours postoperatively.
**P<0.01 between AKI and non-AKI patients.
L-FABP=liver-type fatty acid binding protein; NGAL=neutrophil gelatinase-associated lipocalin